High frequency of intestinal T H 17 cells correlates with microbiota alterations and disease activity in multiple sclerosis

Cited by (337)

Items 101–200 of 337

  1. Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis
    Dorota Kujawa, Łukasz Łaczmański, Sławomir P Budrewicz, Anna Pokryszko‐Dragan, Maria Podbielska · 2023 · Gut Microbes
  2. Gut microbial factors predict disease severity in a mouse model of multiple sclerosis
    Alex Steimle, Mareike Neumann, Erica T. Grant, Stéphanie Willième, Alessandro De Sciscio, Amy Parrish, Markus W. Ollert, Eiji Miyauchi, Tomoyoshi Soga, Shinji Fukuda et al. · 2024 · Nature Microbiology
  3. Multiple sclerosis: a narrative overview of current pharmacotherapies and emerging treatment prospects
    Piotr Olejnik, Zuzanna Roszkowska, Sylwia Adamus, Kaja Kasarełło · 2024 · Pharmacological Reports
  4. The microbiota–gut–brain axis in mental and neurodegenerative disorders: opportunities for prevention and intervention
    Lidya K. Yassin, Jurga Skrabulyte-Barbulescu, Shamsa H. Alshamsi, Sara Saeed, Shamma H. Alkuwaiti, Saif Almazrouei, Abeer Alnuaimi, Shamsa BaniYas, Dana Aldhaheri, Mahra Alderei et al. · 2025 · Frontiers in Aging Neuroscience
  5. Farnesol induces protection against murine CNS inflammatory demyelination and modifies gut microbiome
    Lacey B. Sell, Christina C. Ramelow, Hannah M. Kohl, Kristina R Hoffman, Jasleen Kaur Bains, William J. Doyle, Kevin D. Strawn, Theresa Hevrin, Trevor O. Kirby, K. Michael Gibson et al. · 2021 · Clinical Immunology
  6. Fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis and intestinal inflammation in multiple sclerosis
    Sudhir Kumar Yadav, Naoko Ito, John E. Mindur, Hetal Kumar, Mysra Youssef, Shradha Suresh, Ratuja Kulkarni, Yaritza Rosario, Konstantin E. Balashov, Suhayl S. Dhib-Jalbut et al. · 2022 · Frontiers in Immunology
  7. B Cells and Microbiota in Autoimmunity
    Maria Botía-Sánchez, Marta Eugenia Alarcón-Riquelme, Georgina Galicia · 2021 · International Journal of Molecular Sciences
  8. Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates
    Cosma-Grigorov, Alexandra, Meixner, Holger, Mrochen, Anne, Wirtz, Stefan, Winkler, Jürgen, Marxreiter, Franz · 2020 · Frontiers in Neurology
  9. Microbiota — an amplifier of autoimmunity
    Alexis Vogelzang, Matteo Maurizio Guerrini, Nagahiro Minato, Sidonia Fagarasan · 2018 · Current Opinion in Immunology
  10. Probiotics and the microbiota-gut-brain axis in neurodegeneration: Beneficial effects and mechanistic insights
    Fatemeh Taghizadeh Ghassab, Fatemeh Shamlou Mahmoudi, Reyhaneh Taheri Tinjani, Armitasadat Emami Meibodi, Mohammad Reza Zali, Abbas Yadegar · 2024 · Life Sciences
  11. Microbiota-produced immune regulatory bile acid metabolites control central nervous system autoimmunity
    Martina Antonini Cencicchio, Federico Montini, Vittoria Palmieri, Luca Massimino, Angelica Nobili, Marta Lo Conte, Annamaria Finardi, Alessandra Mandelli, Francesco Asnicar, Radmila Pavlovic et al. · 2025 · Cell Reports Medicine
  12. Gut microbiota and metabolites are linked to disease progression in multiple sclerosis
    Luke Schwerdtfeger, Federico Montini, Toby Black Lanser, Millicent N. Ekwudo, Jonathan D. Zurawski, Shahamat Tauhid, Bonnie I. Glanz, Renxin Chu, Rohit Bakshi, Tanuja Chitnis et al. · 2025 · Cell Reports Medicine
  13. Intestinal Dysbiosis in, and Enteral Bacterial Therapies for, Systemic Autoimmune Diseases
    Eric Vincent Marietta, Ashutosh Kumar Mangalam, Veena Taneja, Joseph A. Murray · 2020 · Frontiers in Immunology
  14. Simulation Model for Hashimoto Autoimmune Thyroiditis Disease
    Marcela Salazar-Viedma, Juan Gabriel Vergaño-Salazar, Luis Pastenes, Vivían D’Afonseca · 2021 · Endocrinology
  15. Efficacy of diet on fatigue, quality of life and disability status in multiple sclerosis patients: rapid review and meta-analysis of randomized controlled trials
    María Dolores Guerrero Aznar, M Dolores Villanueva Guerrero, Jaime Ramos, Sara Eichau Madueño, María Morales Bravo, Rocío López Ruiz, Margarita Beltrán García · 2022 · BMC Neurology
  16. Modulation of multiple sclerosis risk and pathogenesis by the gut microbiota: Complex interactions between host genetics, bacterial metabolism, and diet
    Theresa L. Montgomery, Daniel Peipert, Dimitry N. Krementsov · 2024 · Immunological Reviews
  17. Microbial monotherapy with Prevotella histicola for patients with multiple sclerosis
    Ashutosh Kumar Mangalam, Joseph A. Murray · 2018 · Expert Review of Neurotherapeutics
  18. Sociability in a non-captive macaque population is associated with beneficial gut bacteria
    Katerina V.‐A. Johnson, Karli K. Watson, Robin Dunbar, Philip W. J. Burnet · 2022 · Frontiers in Microbiology
  19. Meta-analysis identifies common gut microbiota associated with multiple sclerosis
    Qingqi Lin, Yair Dorsett, Ali Mirza, Helen L. Tremlett, Laura M. Piccio, Erin E. Longbrake, Siobhán Ní Choileáin, David A. Hafler, Laura M. Cox, Howard L. Weiner et al. · 2024 · Genome Medicine
  20. Exacerbation of Chikungunya Virus Rheumatic Immunopathology by a High Fiber Diet and Butyrate
    Natalie A. Prow, Thiago Dominguez Crespo Hirata, Bing Tang, Thibaut Larcher, Pamela Mukhopadhyay, Tiago Lubiana Alves, Thuy T. Le, Joy Gardner, Yee Suan Poo, Eri Nakayama et al. · 2019 · Frontiers in Immunology
  21. C-type lectin receptors Mcl and Mincle control development of multiple sclerosis–like neuroinflammation
    Marie N’diaye, Susanna Brauner, Sevasti Flytzani, Lara Kular, Andreas Warnecke, Milena Z. Adzemovic, Eliane Piket, Jin-Hong Min, Will Edwards, Filia Mela et al. · 2019 · Journal of Clinical Investigation
  22. Gut commensals, dysbiosis, and immune response imbalance in the pathogenesis of multiple sclerosis
    Jordan S. Brown, Blair Quattrochi, Colleen Everett, Bo‐Young Hong, Jorge Cervantes · 2020 · Multiple Sclerosis Journal
  23. Neuroprotection of cannabidiol in epileptic rats: Gut microbiome and metabolome sequencing
    Xiaoxiang Gong, Lingjuan Liu, Xing‐Fang Li, Jie Xiong, Jie Xu, Ding-An Mao, Liqun Liu · 2022 · Frontiers in Nutrition
  24. Harnessing and delivering microbial metabolites as therapeutics via advanced pharmaceutical approaches
    Lindsey M. Williams, Shijie Cao · 2024 · Pharmacology & Therapeutics
  25. The Gut Microbiome-Neuroglia Axis: Implications for Brain Health, Inflammation, and Disease
    Josué Camberos-Barraza, Alma Marlene Guadrón‐Llanos, Alberto K. De la Herrán-Arita · 2024 · Neuroglia
  26. ILC3, a Central Innate Immune Component of the Gut-Brain Axis in Multiple Sclerosis
    Djordje M. Miljković, Bojan Jevtić, Ivana Stojanović, Mirjana Dimitrijević · 2021 · Frontiers in Immunology
  27. The second brain: The connection between gut microbiota composition and multiple sclerosis
    Melina Farshbafnadi, Elmira Agah, Nima Rezaei · 2021 · Journal of Neuroimmunology
  28. Game of microbes: the battle within – gut microbiota and multiple sclerosis
    Ti-Ara J. Turner, Peter Lehman, Sudeep Ghimire, Shailesh K. Shahi, Ashutosh Kumar Mangalam · 2024 · Gut Microbes
  29. The Emerging World of Microbiome in Autoimmune Disorders: Opportunities and Challenges
    Ashutosh Kumar Mangalam, Meeta Yadav, Rajwardhan Yadav · 2021 · Indian Journal of Rheumatology
  30. The Role of Gut Microbiota in Neuropsychiatric Diseases – Creation of An Atlas-Based on Quantified Evidence
    Bruno Bonnechère, Najaf Amin, Cornelia M. van Duijn · 2022 · Frontiers in Cellular and Infection Microbiology
  31. Advantages and limitations of experimental autoimmune encephalomyelitis in breaking down the role of the gut microbiome in multiple sclerosis
    Esther Melamed, Jamie L. Palmer, Cara Fonken · 2022 · Frontiers in Molecular Neuroscience
  32. Curcumin β-D-Glucuronide Modulates an Autoimmune Model of Multiple Sclerosis with Altered Gut Microbiota in the Ileum and Feces
    Sundar Khadka, Seiichi Omura, Fumitaka Sato, Kazuto Nishio, Hideaki Kakeya, Ikuo Tsunoda · 2021 · Frontiers in Cellular and Infection Microbiology
  33. Eating Hubs in Multiple Sclerosis: Exploring the Relationship Between Mediterranean Diet and Disability Status in Italy
    Federica Felicetti, Silvia Tommasin, Maria Petracca, Laura De Giglio, Flavia Gurreri, Antonio Ianniello, Riccardo Nistri, Carlo Pozzilli, Serena Ruggieri · 2022 · Frontiers in Nutrition
  34. How Microbiota-Derived Metabolites Link the Gut to the Brain during Neuroinflammation
    Jessica Rebeaud, Benjamin Peter, Caroline Pot · 2022 · International Journal of Molecular Sciences
  35. Saussurea involucrata oral liquid regulates gut microbiota and serum metabolism during alleviation of collagen‐induced arthritis in rats
    Shan Cong, Lingrui Wang, Yan Meng, Xuanlin Cai, Chenxi Zhang, Yanqin Gu, Xiumin Ma, Li Luo · 2022 · Phytotherapy Research
  36. Immunopathogenesis of multiple sclerosis: molecular and cellular mechanisms and new immunotherapeutic approaches
    Mansur Aliyu, Fatema Tuz Zohora, Ayça Ceylan, Fariha Hossain, Reza Yazdani, Gholamreza Azizi · 2024 · Immunopharmacology and Immunotoxicology
  37. Glucose metabolism and glycosylation link the gut microbiota to autoimmune diseases
    Lu Wang, Haojie Xu, Huaxia Yang, Jiaxin Zhou, Lidan Zhao, Fengchun Zhang · 2022 · Frontiers in Immunology
  38. New Insights into the Gut Microbiota in Neurodegenerative Diseases from the Perspective of Redox Homeostasis
    Yu Wang, Zhe Zhang, Bowen Li, Bo He, Lei Li, Edouard Collins Nice, Wei Zhang, Jia Feng Xu · 2022 · Antioxidants
  39. The connection between gut microbiota and its metabolites with neurodegenerative diseases in humans
    João Paulo Fabi · 2024 · Metabolic Brain Disease
  40. Gut mucosal and adipose tissues as health targets of the immunomodulatory mechanisms of probiotics
    Tolulope Joshua Ashaolu, Samuel Fernández‐Tomé · 2021 · Trends in Food Science & Technology
  41. Alterations in the human gut microbiome in anti‐N‐methyl‐D‐aspartate receptor encephalitis
    Xue Gong, Xu Liu, Chen Li, Chu Chen, Jingfang Lin, Aiqing Li, Dongmei An, Dong Zhou, Zhen Hong · 2019 · Annals of Clinical and Translational Neurology
  42. MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune Diseases
    Mechelli, Rosella, Romano, Silvia, Romano, Carmela, Morena, Emanuele, Buscarinu, Maria Chiara, Bigi, Rachele, Bellucci, Gianmarco, Reniè, Roberta, Pellicciari, Giulia, Salvetti, Marco et al. · 2021 · Microorganisms
  43. Why Is Multiple Sclerosis More Frequent in Women? Role of the Immune System and of Oral and Gut Microbiota
    Marianna D’Anca, Francesca Romana Buccellato, Gianluca Martino Tartaglia, Massimo DEL FABBRO, Paola C. Muti, Elio Angelo Scarpini, Daniela Galimberti, Laura Ghezzi · 2023 · Applied Sciences
  44. Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis
    Véronique Ferret-Sena, Carlos Capela, Armando Sena · 2018 · International Journal of Molecular Sciences
  45. Effects of Lactobacillus casei Strain T2 (IBRC-M10783) on the Modulation of Th17/Treg and Evaluation of miR-155, miR-25, and IDO-1 Expression in a Cuprizone-Induced C57BL/6 Mouse Model of Demyelination
    Saeideh Gharehkhani Digehsara, Niloofar Name, Behnaz Esfandiari, Elahe Karim, Saba Taheri, Maryam Tajabadi Ebrahimi, Javad Arasteh · 2020 · Inflammation
  46. Serotoninergic system targeting in multiple sclerosis: the prospective for pathogenetic therapy.
    Mikhail Melnikov, Anastasiya Sviridova, Vladimir Rogovskii, Alexander V. Oleskin, Marina Kleopatra Boziki, Christos Bakirtzis, Evangelia Kesidou, Nikolaos Grigoriadis, Alexey Boyко · 2021 · Multiple Sclerosis and Related Disorders
  47. Impact of Helicobacter pylori and metabolic syndrome on mast cell activation-related pathophysiology and neurodegeneration
    Jannis Kountouras, Marina Kleopatra Boziki, Evangelos I. Kazakos, Paschalis Theotokis, Evangelia Kesidou, Maria Nella, Christos Bakirtzis, Eleni Karafoulidou, Elisabeth Vardaka, Maria C. Mouratidou et al. · 2024 · Neurochemistry International
  48. Mast cells and angiogenesis in multiple sclerosis
    D. Ribatti, R. Tamma, T. Annese · 2020 · Inflammation Research
  49. A novel probiotic strain exerts therapeutic effects on mouse model of multiple sclerosis by altering the expression of inflammasome and IDO genes and modulation of T helper cytokine profile
    Saba Sadeghirashed, Fatemeh Kazemi, Saba Taheri, Maryam Tajabadi Ebrahimi, Javad Arasteh · 2021 · Metabolic Brain Disease
  50. Gut microbiome composition is associated with long-term disability worsening in multiple sclerosis
    Lindsay Devolder, Ayla Pauwels, Ann Van Remoortel, Gwen Falony, Sara Vieira‐Silva, Guy Nagels, Jacques De Keyser, Jeroen Raes, Marie Beatrice D'hooghe · 2023 · Gut Microbes
  51. Gut flora in multiple sclerosis: implications for pathogenesis and treatment
    Weiwei Zhang, Ying Wang, Mingqin Zhu, Kangding Liu, Hongliang Zhang · 2023 · Neural Regeneration Research
  52. Gut microbiota in multiple sclerosis and animal models
    Schumacher, Sean M., Doyle, William J., Hill, Kristina, Ochoa‐Repáraz, Javier · 2025 · The FEBS Journal
  53. A probiotic approach identifies a Treg-centred immunoregulation via modulation of gut microbiota metabolites in people with multiple sclerosis and healthy individuals
    Constantin Träger, Maria Kaiser, D. Freudenstein, Simon Heckscher, Katja Dettmer, Peter Josef Oefner, Gerhard Liebisch, Andreas Hiergeist, André Gessner, De-Hyung Lee et al. · 2025 · EBioMedicine
  54. Gut Microbiota-Modulated Metabolomic Profiling Shapes the Etiology and Pathogenesis of Autoimmune Diseases
    Yi-Wen Tsai, Jia-Ling Dong, Yun-Jie Jian, Shin‐Huei Fu, Ming‐Wei Chien, Yuwen Liu, Chao-Yuan Hsu, Huey‐Kang Sytwu · 2021 · Microorganisms
  55. The gut microbiome molecular mimicry piece in the multiple sclerosis puzzle
    Noha Salah Elsayed, Paula Aston, Vishnu R. Bayanagari, Sanjay K. Shukla · 2022 · Frontiers in Immunology
  56. The Impact of Microbiota–Immunity–Hormone Interactions on Autoimmune Diseases and Infection
    Serena Martinelli, Giulia Nannini, Fabio Cianchi, Francesco Coratti, Amedeo Amedei · 2024 · Biomedicines
  57. New therapeutic avenues in multiple sclerosis: Is there a place for gut microbiota-based treatments?
    Lucrezia Irene Maria Campagnoli, Nicoletta Marchesi, Angelica Varesi, Martina Morozzi, Linda Mascione, Giovanni Ricevuti, Ciro Esposito, Nicoletta Galeotti, Alessia Pascale · 2024 · Pharmacological Research
  58. A randomized cross-over trial of prebiotics and probiotics in multiple sclerosis: Trial feasibility, supplement tolerability and symptom abatement
    Rebecca Straus Farber, Elizabeth Walker, Fatoumata Diallo, Kaho B. Onomichi, Claire Riley, Lili Zhang, Wen Zhu, Philip L. De Jager, Zongqi Xia · 2024 · Multiple Sclerosis and Related Disorders
  59. The influence of biogenic amines on Th17-mediated immune response in multiple sclerosis
    Mikhail Melnikov, Vladimir Rogovskii, Alexey Boyко, Mikhail V. Pashenkov · 2018 · Multiple Sclerosis and Related Disorders
  60. A Gut Feeling: The Importance of the Intestinal Microbiota in Psychiatric Disorders
    Javier Ochoa‐Repáraz, Christina C. Ramelow, Lloyd H. Kasper · 2020 · Frontiers in Immunology
  61. Cortex periplocae modulates the gut microbiota to restrict colitis and colitis-associated colorectal cancer via suppression of pathogenic Th17 cells
    Zemin Lin, Li Chen, Mengnan Cheng, Fenghua Zhu, Xiaoqian Yang, Weimin Zhao, Jianping Zuo, Shijun He · 2022 · Biomedicine & Pharmacotherapy
  62. Microbiota-Driven Mechanisms in Multiple Sclerosis: Pathogenesis, Therapeutic Strategies, and Biomarker Potential
    Mohammad Hosein Nemati, Esmaeil Yazdanpanah, Roya Kazemi, Niloufar Orooji, Sepehr Dadfar, Valentyn Oksenych, Dariush Haghmorad · 2025 · Biology
  63. Smoking affects gut immune system of patients with inflammatory bowel diseases by modulating metabolomic profiles and mucosal microbiota
    Eiji Miyauchi, Takashi Taida, Kan Uchiyama, Yumiko Nakanishi, Tamotsu Kato, Shigeo Koido, Nobuo Sasaki, Toshifumi� Ohkusa, Nobuhiro Sato, Hiroshi Ohno · 2025 · Gut
  64. MiR-195 regulates CD40 to maintain Th17/Treg balance in rats with non-alcoholic fatty liver disease
    Li Yang, Haitao Jiang, Li-Bing Han, Li Xiao, Jianhe Gan · 2020 · Biomedicine & Pharmacotherapy
  65. Disease-modifying therapy for multiple sclerosis: Implications for gut microbiota
    Silvy Pilotto, Magdalena Żołędziewska, Giuseppe Fenu, Eleonora E. Cocco, Lorena Lorefice · 2023 · Multiple Sclerosis and Related Disorders
  66. Multiple Sclerosis-Associated Gut Microbiome in the Israeli Diverse Populations: Associations with Ethnicity, Gender, Disability Status, Vitamin D Levels, and Mediterranean Diet
    Zehavit Nitzan, Elsebeth Staun-Ram, Anat Volkowich, Ariel Miller · 2023 · International Journal of Molecular Sciences
  67. Gut-brain communication in demyelinating disorders
    Sami Sauma, Patrizia Casaccia · 2020 · Current Opinion in Neurobiology
  68. Microbiota, IgA and Multiple Sclerosis
    Léo Boussamet, Muhammad Shahid Riaz Rajoka, Laureline Berthelot · 2022 · Microorganisms
  69. Caesarean section and infant formula feeding are associated with an earlier age of onset of multiple sclerosis
    Gloria Dalla Costa, Marzia Anita Lucia Romeo, Federica Esposito, Francesca Sangalli, Bruno Colombo, Marta Radaelli, Lucia Moiola, Gıancarlo Comı, Vittorio Martinelli · 2019 · Multiple Sclerosis and Related Disorders
  70. The multiple sclerosis gut microbiome and disease activity: A systematic review
    Sophia Jette, Constance de Schaetzen, Chia‐Chen Tsai, Helen L. Tremlett · 2024 · Multiple Sclerosis and Related Disorders
  71. The Gut Microbiome and Metabolome in Multiple Sclerosis
    Shailendra Giri, Ashutosh Kumar Mangalam · 2019 · Elsevier eBooks
  72. Liver X receptor regulates Th17 and RORγt+ Treg cells by distinct mechanisms
    Sara Martina Parigi, Srustidhar Das, Annika Frede, Rebeca F. Cardoso, Kumar Parijat Tripathi, Cristian Doñas, Yue O. O. Hu, Per Antonson, Lars G. Engstrand, Jan-Ακε Gustafsson et al. · 2020 · Mucosal Immunology
  73. Dietary wheat amylase trypsin inhibitors exacerbate CNS inflammation in experimental multiple sclerosis
    Victor F. Zevallos, Nir Yogev, Judith Hauptmann, Alexei Nikolaev, Geethanjali Pickert, Valeska Heib, Nicola J. Fittler, Sebastian Steven, Felix Luessi, Manjusha Neerukonda et al. · 2023 · Gut
  74. Polyphenolic Compounds: Orchestrating Intestinal Microbiota Harmony during Aging
    Quélita Cristina Pereira, Isabela Monique Fortunato, Fabrício de Sousa Oliveira, Marisa Claudia Alvarez, Tanila Wood dos Santos, Marcelo Lima Ribeiro · 2024 · Nutrients
  75. Should mast cells be considered therapeutic targets in multiple sclerosis?
    Karen Henriette Pinke, Sofia Fernanda Gonçalves Zorzella-Pezavento, Vanessa Soares Lara, Alexandrina Sartori · 2020 · Neural Regeneration Research
  76. Human NK cells prime inflammatory DC precursors to induce Tc17 differentiation
    Maria Alejandra Clavijo-Salomon, Rosalba Salcedo, Soumen Roy, Rodrigo Xavier das Neves, Amiran H. Dzutsev, Helioswilton Sales‐Campos, Karen Steponavicius Cruz Borbely, Lúcia Mariano da Rocha Silla, Jordan Scott Orange, Emily Margaret Mace et al. · 2020 · Blood Advances
  77. COVID-19 and Multiple Sclerosis: A Complex Relationship Possibly Aggravated by Low Vitamin D Levels
    William Danilo Fernandes de Souza, Denise Morais da Fonseca, Alexandrina Sartori · 2023 · Cells
  78. Visualizing the activation of encephalitogenic T cells in the ileal lamina propria by in vivo two-photon imaging
    Isabel Bauer, Ping Fang, Katrin F. Lämmle, Sofia Tyystjärvi, Dominik Alterauge, Dirk Baumjohann, Hongsup Yoon, Thomas Korn, Hartmut Wekerle, Naoto Kawakami · 2023 · Proceedings of the National Academy of Sciences
  79. Potential Roles of Oral Microbiota in the Pathogenesis of Immunoglobin A Nephropathy
    Jiawei He, Shu‐Feng Zhou, Ping Hou, Yan‐na Wang, Ting Gan, Yang Li, Yang Liu, Lijun Liu, Sufang Shi, Li Zhu et al. · 2021 · Frontiers in Cellular and Infection Microbiology
  80. The intestinal microbiota composition in patients with multiple sclerosis receiving different disease-modifying therapies DMT
    Irina N. Abdurasulova, Е. А. Тарасова, Irina G. Nikiforova, A. G. Ilves, Е. В. Ивашкова, Anna V. Matsulevich, A E Tatarinov, L V Shangina, Е. И. Ермоленко, В. М. Клименко et al. · 2018 · S S Korsakov Journal of Neurology and Psychiatry
  81. Induction of IL-22-Producing CD4+ T Cells by Segmented Filamentous Bacteria Independent of Classical Th17 Cells
    Urmi Roy, Rômulo Silva de Oliveira, Eric J. C. Gálvez, Achim Gronow, Marijana Basic, Laura García Pérez, Nicola Gagliani, André Bleich, Samuel Huber, Till Strowig · 2021 · Frontiers in Immunology
  82. The role of the gut microbiota in neurodegenerative diseases targeting metabolism
    Yufeng Fu, Zhongya Gu, Huấn Cao, Chengchao Zuo, Yaqi Huang, Yu Song, Yongsheng Jiang, Furong Wang · 2024 · Frontiers in Neuroscience
  83. The Core of Gut Life: Firmicutes Profile in Patients with Relapsing-Remitting Multiple Sclerosis
    M Kh Kozhieva, Natalia Naumova, Tatiana Yu. Alikina, Alexey Boyко, Valentin V. Vlassov, Marsel Rasimovich Kabilov · 2021 · Life
  84. Effect of a Fructose-Rich Diet on Gut Microbiota and Immunomodulation: Potential Factors for Multiple Sclerosis
    Stephanie R. Peterson, Soham Ali, Rachel L. Shrode, Ashutosh Kumar Mangalam · 2023 · ImmunoHorizons
  85. Altered microbiota composition reflects enhanced communication in 15q11-13 CNV mice
    Dian Eurike Septyaningtrias, Chia-Wen Lin, Rika Ouchida, Nobuhiro Nakai, Wataru Suda, Masahira Hattori, Hidetoshi Morita, Kenya Honda, Kota Tamada, Toru Takumi · 2019 · Neuroscience Research
  86. The role of the microbiome on immune homeostasis of the host nervous system
    Shaojuan Zhao, Danlei Fu, Yin Lin, Xiaoya Sun, Xiaokang Wang, Xuanzhen Wu, Xuejiao Zhang · 2025 · Frontiers in Immunology
  87. Preclinical Therapy with Vitamin D3 in Experimental Encephalomyelitis: Efficacy and Comparison with Paricalcitol
    Luiza Ayumi Nishiyama Mimura, Thais Fernanda de Campos Fraga‐Silva, Larissa R.C. Oliveira, Larissa Lumi Watanabe Ishikawa, Patrícia Aparecida Borim, Carla de Moraes Machado, José de Anchieta C. Horta‐Júnior, Denise Morais da Fonseca, Alexandrina Sartori · 2021 · International Journal of Molecular Sciences
  88. The association of gut microbiome with recurrent pregnancy loss: A comprehensive review
    Jun Zhu, Jiaxi Jin, Qing Qi, Lisha Li, Jing Zhou, Liwen Cao, Ling Wang · 2023 · Drug Discoveries & Therapeutics
  89. Clinical efficacy and molecular mechanism of Chinese medicine in the treatment of autoimmune thyroiditis
    Ling Zhou, Jinli Luo, Aru Sun, Haoyu Yang, Yi-qun Lin, Lin Han · 2023 · Journal of Ethnopharmacology
  90. Deep DNA metagenomic sequencing reveals oral microbiome divergence between monozygotic twins discordant for multiple sclerosis severity
    Anne Isabelle Boullerne, Guy R. Adami, JOEL L. SCHWARTZ, Demetrios D. Skias, Mark Maienschein‐Cline, Stefan J. Green, Douglas L. Feinstein · 2020 · Journal of Neuroimmunology
  91. Gut microbiota in forty cases of Egyptian relapsing remitting multiple sclerosis
    Sherein Elgendy, Rawan Abd-Elhameed, Enas Daef, Shereen M. Mohammed, Hebatallah M. Hassan, Mohamed A. El‐Mokhtar, Ahmed Nasreldein, Eman Mohamed Khedr · 2021 · Iranian Journal of Microbiology
  92. Rebamipide ameliorates indomethacin-induced small intestinal damage and proton pump inhibitor-induced exacerbation of this damage by modulation of small intestinal microbiota
    Tetsuya Tanigawa, Toshio Watanabe, Akira Higashimori, Sunao Shimada, Hiroyuki Kitamura, Takuya Kuzumoto, Yuji Nadatani, Koji Otani, Shusei Fukunaga, Shuhei Hosomi et al. · 2021 · PLoS ONE
  93. Association of intestinal dysbiosis with susceptibility to multiple sclerosis: Evidence from different population studies (Review)
    María Torres‐Chávez, Nora Magdalena Torres-Carrillo, Ana Moreal‐Lugo, Sandra Garnés Rancurello, Selvasankar Murugesan, Itzae Adonaí Gutiérrez-Hurtado, J. Raul Beltran-Ramirez, Elena Sandoval‐Pinto, Norma Torres‐Carrillo · 2023 · Biomedical Reports
  94. The link between gut microbiota and multiple sclerosis from the perspective of barrier function
    Jingru Ren, Zhenyu Niu, Jianchun Wang, Jing Guo, Hong-Jun Hao, Feng Gao, Ran Liu, Zhaoxia Wang · 2025 · Frontiers in Immunology
  95. The Microbiome–Neurodegeneration Interface: Mechanisms, Evidence, and Future Directions
    Lilia Böckels, Daniel Alexa, Dorin Cristian Antal, Cristina Gațcan, Cosmin Alecu, Kristina Kacani, Raul Andrei Cretu, Emanuel-Andrei Piseru, Robert Valentin Bîlcu, Dan Iulian Cuciureanu · 2026 · Cells
  96. Genetic risk score in multiple sclerosis is associated with unique gut microbiome
    Noha Salah Elsayed, Robert K. Valenzuela, Terrie Kitchner, Thao Nhien Le, John G. Mayer, Zheng-Zheng Tang, Vishnu R. Bayanagari, Qiongshi Lu, Paula Aston, Karthik Anantharaman et al. · 2023 · Scientific Reports
  97. The role of the “gut microbiota-mitochondria” crosstalk in the pathogenesis of multiple sclerosis
    Huan Tian, Dunbing Huang, Jiaqi Wang, Huaqiang Li, Jiaxin Gao, Yue Zhong, Libin Xia, Anren Zhang, Zhonghua Lin, Xiaohua Ke · 2024 · Frontiers in Microbiology
  98. Relationship between gut microbiota and multiple sclerosis: a scientometric visual analysis from 2010 to 2023
    Qingrong Ouyang, Hao Yu, Lei Xu, Ming Yu, Yunwei Zhang · 2024 · Frontiers in Immunology
  99. Disentangling the molecular mechanisms of multiple sclerosis: The contribution of twin studies
    Maria Chiara Buscarinu, Arianna Fornasiero, Michela Ferraldeschi, Silvia Romano, Roberta Reniè, Emanuele Morena, Carmela Romano, Giulia Pellicciari, Anna Chiara Landi, Corrado Fagnani et al. · 2020 · Neuroscience & Biobehavioral Reviews
  100. Surface Layer Protein A Expressed in Clostridioides difficile DJNS06-36 Possesses an Encephalitogenic Mimotope of Myelin Basic Protein
    John E. Mindur, Sudhir Kumar Yadav, Naoko Ito, Mitsutoshi Senoh, Haru Kato, Suhayl S. Dhib-Jalbut, Kouichi Ito · 2020 · Microorganisms